Monoklonaalinen vasta-aine

摘要

The invention concerns new monoclonal antibodies that identify glycolipid antigens associated with human non small-cell lung carcinoma (NSCLC) and with other specific human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies can be used in diagnostic methods, like detection of malignant cells associated with NSCLC.